Regulation of the Shiga-like toxin II operon in Escherichia coli. 1996

I Mühldorfer, and J Hacker, and G T Keusch, and D W Acheson, and H Tschäpe, and A V Kane, and A Ritter, and T Olschläger, and A Donohue-Rolfe
Lehrstuhl fäur Molekulare Infektionsbiologie, Universität Würzburg, Germany.

Investigations of the regulation of the bacteriophage-encoded Shiga-like toxin II (SLT-II) in Escherichia coli demonstrated that bacteriophages exhibit a regulatory impact on toxin production by two mechanisms. Firstly, replication of the toxin-converting bacteriophages brings about an increase in toxin production due to concomitant multiplication of toxin gene copies. Secondly, an influence of a phage-encoded regulatory molecule was demonstrated by using low-copy-number plasmid pADR-28, carrying a translational gene fusion between the promoter and proximal portion of slt-IIA and the structural gene for bacterial alkaline phosphatase (phoA). PhoA activity, reflecting the slt-II promoter activity, was significantly enhanced in E. coli strains which and been lysogenized with an SLT-I or SLT-II-converting bacteriophage (H-19B or 933W, respectively) or bacteriophage lambda. Both mechanisms are dependent on bacteriophage induction and hence are recA dependent. Moreover, the study revealed that the DNA-binding protein H-NS has a regulatory impact on both bacteriophage-mediated SLT-II synthesis and the activity of the slt-II promoter of plasmid pADR-28. While a slight impact of growth temperature on SLT-II expression was observed, no impact of either osmolarity, pH, oxygen tension, acetates, iron level, or utilized carbon source could be demonstrated.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009876 Operon In bacteria, a group of metabolically related genes, with a common promoter, whose transcription into a single polycistronic MESSENGER RNA is under the control of an OPERATOR REGION. Operons
D011938 Rec A Recombinases A family of recombinases initially identified in BACTERIA. They catalyze the ATP-driven exchange of DNA strands in GENETIC RECOMBINATION. The product of the reaction consists of a duplex and a displaced single-stranded loop, which has the shape of the letter D and is therefore called a D-loop structure. Rec A Protein,RecA Protein,Recombinases, Rec A
D004768 Enterotoxins Substances that are toxic to the intestinal tract causing vomiting, diarrhea, etc.; most common enterotoxins are produced by bacteria. Staphylococcal Enterotoxin,Enterotoxin,Staphylococcal Enterotoxins,Enterotoxin, Staphylococcal,Enterotoxins, Staphylococcal
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D006463 Hemolytic-Uremic Syndrome A syndrome that is associated with microvascular diseases of the KIDNEY, such as RENAL CORTICAL NECROSIS. It is characterized by hemolytic anemia (ANEMIA, HEMOLYTIC); THROMBOCYTOPENIA; and ACUTE RENAL FAILURE. Gasser's Syndrome,Gasser Syndrome,Gassers Syndrome,Hemolytic Uremic Syndrome,Syndrome, Hemolytic-Uremic
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D001427 Bacterial Toxins Toxic substances formed in or elaborated by bacteria; they are usually proteins with high molecular weight and antigenicity; some are used as antibiotics and some to skin test for the presence of or susceptibility to certain diseases. Bacterial Toxin,Toxins, Bacterial,Toxin, Bacterial
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D015964 Gene Expression Regulation, Bacterial Any of the processes by which cytoplasmic or intercellular factors influence the differential control of gene action in bacteria. Bacterial Gene Expression Regulation,Regulation of Gene Expression, Bacterial,Regulation, Gene Expression, Bacterial

Related Publications

I Mühldorfer, and J Hacker, and G T Keusch, and D W Acheson, and H Tschäpe, and A V Kane, and A Ritter, and T Olschläger, and A Donohue-Rolfe
November 1990, Journal of bacteriology,
I Mühldorfer, and J Hacker, and G T Keusch, and D W Acheson, and H Tschäpe, and A V Kane, and A Ritter, and T Olschläger, and A Donohue-Rolfe
September 1989, Infection and immunity,
I Mühldorfer, and J Hacker, and G T Keusch, and D W Acheson, and H Tschäpe, and A V Kane, and A Ritter, and T Olschläger, and A Donohue-Rolfe
July 1993, Gene,
I Mühldorfer, and J Hacker, and G T Keusch, and D W Acheson, and H Tschäpe, and A V Kane, and A Ritter, and T Olschläger, and A Donohue-Rolfe
August 1986, The Journal of infectious diseases,
I Mühldorfer, and J Hacker, and G T Keusch, and D W Acheson, and H Tschäpe, and A V Kane, and A Ritter, and T Olschläger, and A Donohue-Rolfe
May 1990, Infection and immunity,
I Mühldorfer, and J Hacker, and G T Keusch, and D W Acheson, and H Tschäpe, and A V Kane, and A Ritter, and T Olschläger, and A Donohue-Rolfe
September 1987, Journal of bacteriology,
I Mühldorfer, and J Hacker, and G T Keusch, and D W Acheson, and H Tschäpe, and A V Kane, and A Ritter, and T Olschläger, and A Donohue-Rolfe
August 2000, Journal of natural toxins,
I Mühldorfer, and J Hacker, and G T Keusch, and D W Acheson, and H Tschäpe, and A V Kane, and A Ritter, and T Olschläger, and A Donohue-Rolfe
November 1987, Infection and immunity,
I Mühldorfer, and J Hacker, and G T Keusch, and D W Acheson, and H Tschäpe, and A V Kane, and A Ritter, and T Olschläger, and A Donohue-Rolfe
June 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
I Mühldorfer, and J Hacker, and G T Keusch, and D W Acheson, and H Tschäpe, and A V Kane, and A Ritter, and T Olschläger, and A Donohue-Rolfe
April 1991, Infection and immunity,
Copied contents to your clipboard!